Navigation Links
Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
Date:1/24/2013

nistrative358,854(30,460)(501)327,893  Depreciation and amortization117,708(3,470)(2,347)111,891  Goodwill impairment charge17,959(17,959)-Total costs and expenses2,249,882(33,930)(39,127)(18,028)-2,158,797Income from operations115,87733,93039,1279,274-198,208Other expense, net:  Interest expense, net3,5063,506  Foreign exchange transaction loss, net1,4741,474  Impairment of equity investment7,373(7,373)-  Gain on sale of investment(1,459)1,459-  Loss on sale of business169169Other expense, net11,063-(5,914)--5,149Income before taxes and equity investee earnings104,81433,93045,0419,274-193,059Taxes on income10,09910,7856,0092,74111,50141,135Equity investee earnings1717Net income $
94,732$
23,145$
39,032$
,533$
(11,501)$
51,941Basic earnings per share$
.73$
.42$
.71$
.12$
(0.21)$
2.77Weighted average shares outstanding - basic54,844,64154,844,64154,844,64154,844,64154,844,64154,844,641Diluted earnings per share$
.68$
.41$
.69$
.12$
(0.20)$
2.70Weighted average shares outstanding - diluted56,290,01056,290,01056,290,01056,290,01056,290,01056,290,010(1) Represents costs incurred to better align capacity to preclinical market demand and reduce overall cost structure.(2) Consists of inventory impairment and costs associated with the expected settlement of an inventory supply agreement ($21,168), goodwill impairment ($17,959), impairment of equity investment ($7,373) and a gain on the sale of an investment $1,459.(3) Represents results of operations at sites that were closed during the period.(4) Primarily represents favorable resolutions of income tax matters. COVANCE INC.GAAP to Pro Forma ReconciliationFor the year ended December 31, 2011(Dollars in thousands, except per share data)(UNAUDITED)AdjustmentsGAAP Restructuring Activities (1)Other
Charges (2)Income Tax Items (3)Pro FormaNet revenues$  2,095,938$  2,095,938R
'/>"/>
SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)... Nov. 25, 2014  Array BioPharma Inc. ... that its Chief Executive Officer, Ron ... upcoming conferences.  The public is welcome to ... the Array BioPharma website:  www.arraybiopharma.com .Event: Piper ... p.m.  Eastern Time Location: Palace Hotel, New ...
(Date:11/26/2014)... NEW YORK and HERZLIYA PITUACH, Israel, Nov. ... IMNP; "Immune" or "the Company"), a clinical stage ... commercialization of targeted therapeutics for the treatment of ... of its previously announced underwritten public offering of ... share of the Company,s common stock, par value ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5
... , June 4 Amgen executive Alan ... of BeneChill, a privately held medical device company launching its ... response teams in the field, later this year in ... the pharmaceutical, biotechnology, medical device and diagnostic industries, Mr. Raffensperger ...
... BURLINGTON, Vt ., June 4 Mach 7 ... solutions, has relocated its global headquarters from suburban Chicago ... as the company,s base for Americas, sales and professional service operations, ... management and strategic R&D functions. , ...
Cached Medicine Technology:Veteran International Health Care Executive Appointed CEO of BeneChill(R) 2Mach 7 Technologies Establishes New Headquarters in Burlington, VT 2
(Date:11/26/2014)... German scientists say carbon-based synthetic molecules used ... that looks and acts similar to asbestos-induced mesothelioma. Surviving ... research. Click here to read it now. ... Experimental Medicine in Hannover injected 500 lab rats with ... eventually developed mesothelioma , how quickly it developed ...
(Date:11/26/2014)... Loffler Companies has been selected as a 2014 ... information and news publication for resellers of imaging technology, ... Loffler has earned this prestigious award and the seventh ... honor the best and the brightest in the imaging ... chosen for their innovative marketing and sales programs, community ...
(Date:11/26/2014)... 2014 Senior Planning Services, providing “expert ... nonprofit organization providing the adult demographic education and ... seniors navigate the rough seas of applying for Medicaid. ... on the topic of Medicaid eligibility and proper planning, ... of applying for this coverage. , Senior Planning ...
(Date:11/26/2014)... NY (PRWEB) November 26, 2014 Call ... research requirements or email the details on sales(at)researchmoz(dot)us ... diabetes and drug discovery market 2014" with deep study ... is the result of high blood sugar. The global ... directly linked to the growing number of diabetics in ...
(Date:11/26/2014)... 26, 2014 Louisiana Back Institute, ... specialists in minimally invasive spine surgery, announces today ... the rapidly growing provider network of orthopedic spine ... coincides with the network’s continuing success providing the ... Louisiana residents who are suffering from orthopedic spine ...
Breaking Medicine News(10 mins):Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2
... with endometriosis may one day lead to new ways ... research suggests. What's more, the researchers may have also ... consequence of the condition. ,Anywhere from 10 to 15 ... when the tissue //that lines the uterus, the endometrium, ...
... take the newer, lower-dose birth control pills are not increasing ... birth control pills debuted in the 1960s, doctors have worried ... studies looking at the link, however, have looked at women ... levels of estrogen compared to those in use today. Whether ...
... may have solved the mystery of why dengue fever, unlike ... Dengue is a debilitating, sometimes fatal illness endemic to much ... by high fever, bone and muscle pain and -- in ... ,Dengue is also unusual in that //symptoms are more severe ...
... aren’t beneficial in the prevention of heart disease or ... speculated antioxidant vitamins, such as beta carotene (a form ... role in helping people avoid cardiovascular disease. The vitamins ... of dangerous plaque. Several preclinical studies show supplementing //the ...
... experienced a significant reduction in blood pressure as ... according to a new study. ,To investigate the ... the rest-activity cycle, Ramon C. Hermida, Ph.D., of ... Universitario, Spain, and colleagues studied a group of ...
... high cholesterol levels are more likely to develop high ... eating habits and cholesterol levels of nearly 450 preschool ... by doctors and had their HDL, or good cholesterol, ... the study show children with the highest levels of ...
Cached Medicine News:Health News:Scientists crack dengue fever puzzle 2Health News:Night Time Aspirin Regimen Found to Reduce Blood Pressure 2
... Stylish and comfortable eye protection ... approximately 90% of scatter radiation. Our high ... protection and comfort with minimized weight. Our ... leaded) optics that meet all industry standards. ...
Uvex Patriot Frame...
... with the safety and comfort of the practitioner ... called SF-6) leaded glass, the industry standard for ... set for optical clarity, visible light transmission, power ... protecting your eyes, it also helps you look ...
... Radiation Protection Goggles ... can be used by ... mm leaded glass, 1.0 ... shields provide increased scatter ...
Medicine Products: